Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.

Translated title of the contribution: Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.
Original language	Undefined/Unknown
Pages (from-to)	389-392
Number of pages	4
Journal	Expert Opinion on Therapeutic Patents
Volume	23
Issue number	3
DOIs	https://doi.org/10.1517/13543776.2013.765406
Publication status	Published - 2013

Access to Document

@article{37fd8045316c49daa6714ff9517d65c2,

title = "Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.",

author = "T.P. Rygiel and B. Luijk and L. Meyaard",

year = "2013",

doi = "10.1517/13543776.2013.765406",

language = "Undefined/Unknown",

volume = "23",

pages = "389--392",

journal = "Expert Opinion on Therapeutic Patents",

issn = "1354-3776",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - Use of an anti-CD200 antibody for prolonging the survival of allografts: a patent evaluation of WO2012106634A1.

AU - Rygiel, T.P.

AU - Luijk, B.

AU - Meyaard, L.

PY - 2013

Y1 - 2013

U2 - 10.1517/13543776.2013.765406

DO - 10.1517/13543776.2013.765406

M3 - Article

C2 - 23351009

SN - 1354-3776

VL - 23

SP - 389

EP - 392

JO - Expert Opinion on Therapeutic Patents

JF - Expert Opinion on Therapeutic Patents

IS - 3

ER -